表紙:バキュロウイルス発現システム市場:用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1364689

バキュロウイルス発現システム市場:用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Baculovirus Expression System Market, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 301 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
バキュロウイルス発現システム市場:用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年10月01日
発行: AnalystView Market Insights
ページ情報: 英文 301 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

バキュロウイルス発現システム市場規模は2022年に3億5,070万米ドルとなり、2023年から2030年にかけてCAGR 9.2%で拡大

バキュロウイルス発現システム市場-市場力学

生活習慣病の高い蔓延が市場需要を促進すると予想される

生活習慣病の治療薬や診断薬となり得る新規タンパク質、酵素、その他の化合物に関する調査が増加しています。このため、これらのタンパク質を活性型で、十分な量を、必要な翻訳後修飾を施した状態で生産できるシステムが必要とされています。生活習慣病は、しばしば非感染性疾患(NCDs)として知られ、心血管疾患、糖尿病、肥満、一部の悪性腫瘍を含みます。このような疾病が急増しているため、新規で効果的な治療法の開発が急務となっています。

世界保健機関(WHO)によると、毎年1,700万人が70歳までに非感染性疾患で死亡しており、このうち86%が中低所得国で発生しています。バキュロウイルスは遺伝子治療への応用の可能性が研究されているため、何らかのブレークスルーがあれば、BESに新たなビジネスチャンスがもたらされる可能性があります。しかし、組換え、ウイルス増幅、タンパク質採取を含むBESプロセスは複雑で時間がかかるため、潜在的なユーザーの意欲をそぐ可能性があります。

バキュロウイルス発現システム市場-セグメンテーション分析:

バキュロウイルス発現システムの世界市場は、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は、アプリケーションに基づいて3つのカテゴリに分かれています:治療、調査、産業。治療分野が市場を独占しています。BESは哺乳類のような翻訳後修飾を導入する能力があるため、治療用タンパク質合成の代替品として支持されています。治療用途で有用かつ安全であるためには、これらのタンパク質はしばしば特殊な変化を必要とします。

市場はエンドユーザーによって2つのカテゴリーに分けられる:製薬・バイオテクノロジー企業、受託研究機関、受託製造機関、学術研究機関、その他。彼らは創薬、ワクチン開発、治療用タンパク質の製造にBESを活用しています。彼らの事業規模や製造する製品の商業的関連性を考えると、市場需要のかなりの部分を占めています。

バキュロウイルス発現システム市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。北米は、製薬・バイオテクノロジー分野の高成長により、市場の成長を支配すると予想されます。米国の製薬会社やバイオテクノロジー会社は、研究開発にかける世界の支出額の上位に入る。この投資が、BESを含む効果的なタンパク質発現プラットフォームへの需要を後押ししています。製薬業界の統計によると、米国は2025年に6,050億~6,350億米ドルを医薬品に費やすと予想されています。また、現在米国で雇用されている薬剤師は310,574人以上です。欧州は、タンパク質研究のための資金が増加しているため、この市場の成長にとって2番目に大きな地域になると予想されています。

バキュロウイルス発現システム市場-競合情勢:

バキュロウイルス発現システム(BES)市場には、BESに適した製品、サービス、ソリューションを提供する多様なプレーヤーが存在します。これらのプレーヤーは、製品の品質、革新性、価格設定、アフターサービスなどを基準に競争しています。各社は、より高い収量とより良いタンパク質の品質を達成するため、BES製品の効率を高める努力を続けています。各社は、バイオテクノロジーの研究開発および利用開発として、特に需要が拡大している新興分野で、世界のリーチの拡大に努めています。例えば、メルク社はBESに関連するツールとサービスを提供しています。同社が提供するものには、タンパク質の収量と品質を最大化するために調整されたキット、試薬、サービスが含まれます。

目次

第1章 バキュロウイルス発現システム市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 バキュロウイルス発現システムの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 バキュロウイルス発現システム産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 バキュロウイルス発現システム市場:COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 バキュロウイルス発現システム市場情勢

  • バキュロウイルス発現システム市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 バキュロウイルス発現システム市場- アプリケーション別

  • 概要
    • アプリケーション別のセグメントシェア分析
      • 治療用
      • 調査
      • 産業用

第8章 バキュロウイルス発現システム市場- エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
      • 製薬会社およびバイオテクノロジー会社
      • 受託調査機関
      • 受託製造組織
      • 学術調査機関
      • その他

第9章 バキュロウイルス発現システム市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- バキュロウイルス発現システム業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific Inc
    • Promega corporation
    • New England Biolabs
    • Merck Millipore
    • Genscript USA Inc
    • Clontech Laboratories

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Baculovirus Expression System Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Baculovirus Expression System Market, by Application 2018-2030 (USD Million)
  • TABLE Baculovirus Expression System Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Baculovirus Expression System Market, by End-User 2018-2030 (USD Million)
  • TABLE Baculovirus Expression System Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Baculovirus Expression System Market, by Region 2018-2030 (USD Million)
  • TABLE North America Baculovirus Expression System Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Baculovirus Expression System Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Baculovirus Expression System Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Baculovirus Expression System Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Baculovirus Expression System Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Baculovirus Expression System Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Baculovirus Expression System Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Baculovirus Expression System Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Baculovirus Expression System Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Baculovirus Expression System Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Baculovirus Expression System Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Baculovirus Expression System Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Baculovirus Expression System Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Baculovirus Expression System Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Baculovirus Expression System Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Baculovirus Expression System Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Baculovirus Expression System Market share and leading players, 2022
  • FIGURE Europe Baculovirus Expression System Market share and leading players, 2022
  • FIGURE Asia Pacific Baculovirus Expression System Market share and leading players, 2022
  • FIGURE Latin America Baculovirus Expression System Market share and leading players, 2022
  • FIGURE Middle East and Africa Baculovirus Expression System Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Baculovirus Expression System Market share analysis by country, 2022
  • FIGURE Germany Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Baculovirus Expression System Market share analysis by country, 2022
  • FIGURE India Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Baculovirus Expression System Market share analysis by country, 2022
  • FIGURE Brazil Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Baculovirus Expression System Market share analysis by country, 2022
  • FIGURE Saudi Arabia Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Baculovirus Expression System Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1760

REPORT HIGHLIGHT

Baculovirus Expression System Market size was valued at USD 350.7 Million in 2022, expanding at a CAGR of 9.2% from 2023 to 2030.

The baculovirus expression system has been widely employed in the expression of recombinant proteins within insect cells for many years. Recombinant Baculovirus vectors for temporary and stable gene delivery into various mammalian cell lines have recently been developed. The Baculovirus Expression System is a potent and adaptable platform for producing recombinant proteins, particularly those that require specific post-translational modifications. Its powers go beyond just protein expression, with potential medicinal applications as well.

Baculovirus Expression System Market- Market Dynamics

The high prevalence of lifestyle diseases is expected to propel market demand

There has been a rise in research into novel proteins, enzymes, and other compounds that can act as possible treatments or diagnostics for lifestyle disorders. This necessitates systems capable of producing these proteins in their active forms, in adequate quantities, and with the necessary post-translational modifications. Lifestyle diseases, often known as non-communicable diseases (NCDs), include cardiovascular disease, diabetes, obesity, and some malignancies. Because of this spike, there is an urgent need for novel and effective therapeutic methods.

According to the World Health Organization, each year, 17 million people die from non-communicable diseases before age 70; 86% of these premature deaths occur in low- and middle-income countries. As baculoviruses are being researched for possible applications in gene therapy, any breakthroughs could open up new business opportunities for BES. However, The BES process, which involves recombination, virus amplification, and protein harvesting, can be complex and lengthy, which may discourage some potential users.

Baculovirus Expression System Market- Key Insights

  • As per the analysis shared by our research analyst, the global Baculovirus Expression System market is estimated to grow annually at a CAGR of around 9.2% over the forecast period (2023-2030)
  • The Baculovirus Expression System industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on Application segmentation, Therapeutic was predicted to show maximum market share in the year 2022
  • Based on End-User segmentation, pharmaceutical and Biotechnology was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Baculovirus Expression System Market- Segmentation Analysis:

The Global Baculovirus Expression System Market is segmented on the basis of Application, End-User, and Region.

The market is divided into three categories based on Application: Therapeutic, Research, and Industrial. The therapeutic segment dominates the market. The BES's capacity to introduce mammalian-like post-translational modifications has made it a favored alternative for therapeutic protein synthesis. To be useful and safe in therapeutic applications, these proteins frequently require specialized changes.

The market is divided into two categories based on End-User: Pharmaceutical and Biotechnology companies, Contract research organizations, contract manufacturing organizations, Academic research institutes, and Others. pharmaceutical and Biotechnology companies dominate the market growth. They utilize BES for drug discovery, vaccine development, and the manufacture of therapeutic proteins. Given the size of their operations and the commercial relevance of the products they manufacture; they account for a sizable amount of market demand.

Baculovirus Expression System Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market due to the high growth of the pharmaceutical and biotechnological sectors. U.S. pharmaceutical and biotech companies are among the top global spenders on research and development. This investment drives the demand for effective protein expression platforms, including BES. According to pharmaceutical industry statistics, The U.S. is expected to spend USD605-USD635 billion on medicine in 2025. And there are more than 310,574 pharmacists currently employed in the United States. Europe is expected to second largest region for the growth of this market, due to increasing funding for protein research.

Baculovirus Expression System Market- Competitive Landscape:

The Baculovirus Expression System (BES) market has a diverse set of players offering products, services, and solutions suited to the BES. These players compete on the basis of product quality, innovation, pricing, and after-sales services. Companies are constantly striving to increase the efficiency of their BES products in order to achieve higher yields and better protein quality. Companies are striving to expand their reach as a biotechnology research and use develop globally, particularly in emerging areas where demand is expanding. For example, Merck provides tools and services related to the BES. Their offerings include kits, reagents, and services tailored for maximum protein yield and quality.

Recent Developments:

On May 2, 2018, Historically, undefined insect media components such as yeast late have made it challenging to achieve consistent results and protein yields across multiple experiments. These factors can significantly slow vaccine development at a time when manufacturers are under pressure to develop vaccines faster and more efficiently. Focused on removing barriers to vaccine development and production, Thermo Fisher Scientific announced today its Gibco ExpiSf system, the first-ever chemically defined insect protein expression system.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BACULOVIRUS EXPRESSION SYSTEM MARKET KEY PLAYERS

  • Thermo Fisher Scientific Inc
  • Promega corporation
  • New England Biolabs
  • Merck Millipore
  • Genscript USA Inc
  • Clontech Laboratories

GLOBAL BACULOVIRUS EXPRESSION SYSTEM MARKET, BY APPLICATION

  • Therapeutic
  • Research
  • Industrial

GLOBAL BACULOVIRUS EXPRESSION SYSTEM MARKET, BY END-USER

  • Pharmaceutical and Biotechnology companies
  • Contract research organizations
  • contract manufacturing organization
  • Academic research institutes
  • Others

GLOBAL BACULOVIRUS EXPRESSION SYSTEM MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Baculovirus Expression System Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Baculovirus Expression System Market Snippet by Application
    • 2.1.2. Baculovirus Expression System Market Snippet by End-User
    • 2.1.3. Baculovirus Expression System Market Snippet by Country
    • 2.1.4. Baculovirus Expression System Market Snippet by Region
  • 2.2. Competitive Insights

3. Baculovirus Expression System Key Market Trends

  • 3.1. Baculovirus Expression System Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Baculovirus Expression System Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Baculovirus Expression System Market Opportunities
  • 3.4. Baculovirus Expression System Market Future Trends

4. Baculovirus Expression System Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Baculovirus Expression System Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Baculovirus Expression System Market Landscape

  • 6.1. Baculovirus Expression System Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Baculovirus Expression System Market - By Application

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
      • 7.1.1.1. Therapeutic
      • 7.1.1.2. Research
      • 7.1.1.3. Industrial

8. Baculovirus Expression System Market - By End-User

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
      • 8.1.1.1. Pharmaceutical and Biotechnology companies
      • 8.1.1.2. Contract research organizations
      • 8.1.1.3. Contract Manufacturing Organization
      • 8.1.1.4. Academic research institutes
      • 8.1.1.5. Others

9. Baculovirus Expression System Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Baculovirus Expression System Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Baculovirus Expression System Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Baculovirus Expression System Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Baculovirus Expression System Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Baculovirus Expression System Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Baculovirus Expression System Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Thermo Fisher Scientific Inc
    • 10.2.2. Promega corporation
    • 10.2.3. New England Biolabs
    • 10.2.4. Merck Millipore
    • 10.2.5. Genscript USA Inc
    • 10.2.6. Clontech Laboratories

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us